These stocks are showing short-term gain catalysts and longer-term growth potential. Here's how to trade them.
The PC market is about to be flooded with Chromebooks that can run Android apps. Android's popularity and other factors make this a big threat to Microsoft's Windows business.
The president's call to rework or scrap the trade deal with Canada and Mexico, in place since 1994, has far-reaching implications--from candy companies to railways.
Donald Trump has had a lot of success in business, but how will he be for the economy as president? Here's how his economic policies will play out.
Investors are ditching the Trump trade and can now zero in on what they think of the economy.
Jim Cramer looks for domestic stocks he thinks will benefit from lower taxes and deregulation in the Trump era.
These three pot stocks are safer than the small-cap players in the sector.
Will the merger with Walgreens go through? Investors -- even Jim Cramer -- can't be sure, and that is affecting the drug store stock.
President Donald Trump's decision to shelve the Trans-Pacific Partnership doesn't come as a surprise to much of corporate America, but it doesn't mean they're all happy about it either.
Guaranteed demand makes shares of these companies excellent choices for investors.
One company could be a loser.
The new president and his administration committed to protectionist policies on Monday, giving Wall Street a sliver of clarity over how the next four years could play out.
Here's how to trade seven of the most active stocks on the market Monday.
Jack Ma's company is expected to report earnings on Jan. 24 before market open.
These 10 dividend stocks are some of the highest-yielding holdings in Warren Buffett's Berkshire Hathaway portfolio.
Do you really want to live in Buffalo, under eight feet of snow? The most affordable places to live in the U.S. are not the ritziest.
The company could soon see some tire kickers.
Pai was promoted to become the next commissioner of the FCC on Monday, a move likely to win support from broadband providers who opposed Obama's net neutrality regulations.
Don't care if you need to be on call or work long hours? Then these high-paying jobs could be for you.
It's unclear how much of the hefty $4,500 price pharmacy benefit managers or insurers will agree to pay to keep Auvi-Q free for most patients.